WinstonWınston
Back
Synvista Therapeutics logo

Synvista Therapeutics

SYNI
Medical - Pharmaceuticals · Healthcare
Price
$0.00
-0.08 (-100.00%)
Market Cap
$3
Winston Score
–
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.
Track this stock — start free trial

Winston Score History

The full picture

Synvista Therapeutics is a small pharmaceutical company focused on developing drug treatments for diseases. The company has historically worked on compounds targeting conditions related to aging and metabolic disorders, with potential customers being patients and healthcare providers in the medical community.

Synvista has operated as a clinical-stage or early-stage pharmaceutical company, meaning it has not yet generated significant revenue from selling approved drugs. With a market cap effectively near zero, the company is extremely small and has limited financial resources compared to larger pharmaceutical peers. The primary risk facing Synvista is its ability to secure funding to continue operations and advance any drug candidates through the costly clinical trial process required for regulatory approval.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Insider Activity

6.1%ownership

→ Flat

Insider ownership roughly steady over the past year

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
no trend
Data not available
Profit after running costs
Operating Margin
N/A
no trend
Data not available
Return on the money invested
ROCE
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
no trend
Data not available
Profit growth
EPS YoY
N/A
no trend
Data not available
How steady the profit is
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
no trend
Data not available
Spare cash per sale
FCF Margin
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
no trend
Data not available
Covers its interest
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/A
no trend
Data not available
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial